Abstract
The radioimmunoassay (RIA) method was first developed by S.A. Berson and R.S. Yalow in the late 1950s for the determination of insulin in human serum. The method is employed to determine numerous hormones, enzymes, antigens, and drugs in minute quantities (10-9-10-12Af) in human plasma in order to assess various disease conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Chase GC, Rabinowitz JL. Principles of Radioisotope Methodology. 3rd ed. Minneapolis: Burgess; 1970.
Moss AJ Jr, Dalrymple GV, Boyd CM, eds. Practical Radioimmunoassay. St Louis: Mosby; 1976.
Odell WD, Daughaday WH, eds. Principles of Competitive Protein-Binding Assays. Philadelphia: Lippincott; 1974.
Rothfeld B, ed. Nuclear Medicine In Vitro. Philadelphia: Lippincott; 1974.
Thorell JI, Larson SM. Radioimmunoassay and Related Techniques. St Louis: Mosby; 1978.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Saha, G.B. (1998). In Vitro and In Vivo Nonimaging Tests. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2934-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2934-4_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2936-8
Online ISBN: 978-1-4757-2934-4
eBook Packages: Springer Book Archive